News Releases

Mr. Rabinovitch is one of the global cannabis senior executives to participate NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure") today announced that Alexander Rabinovitch, CEO of InterCure,

Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million Adjusted EBITDA (1) of $6 Million Strong balance sheet with over $45 million cash and Net current assets of over $72 million NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 (GLOBE

The Company will be featured on the Claman Countdown show on Monday to discuss its strong 2022 results and recent partnership with Mike Tyson NEW YORK and TORONTO and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: INCR ) (TSX: INCR.U) (TASE: INCR) ("InterCure'' or the "Company"), the

NEW YORK and TORONTO and HERZLIYA, Israel, April 25, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the leading medical cannabis company outside of North America announces that on April 24, 2023, it was informed

Leading Global Pharmaceutical Cannabis Company, InterCure, signed an initial collaboration agreement with legendary boxer, entrepreneur and cannabis advocate Mike Tyson’s premium cannabis brand NEW YORK and TORONTO and HERZLIYA, Israel, April 20, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd .

NEW YORK , TORONTO , and HERZLIYA, Israel , April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today that it has rescheduled its previously announced conference call to discuss the company's financial

Record fiscal year 202 2 revenue of $ 150 million Record fiscal year 202 2 Adjusted EBITDA *  of $ 3 2 million Record fiscal year 202 2 net income of $ 17 million Generated $20 Million cash flow from operations Strong balance sheet with over $ 95 million cash NEW YORK, TORONTO, and HERZLIYA,

NEW YORK, TORONTO, and HERZLIYA, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“ InterCure ” or the “ Company ”) the biggest and most profitable cannabis company outside of north America, announced today that it has filed a lawsuit

NEW YORK and TORONTO and HERZLIYA, Israel, Feb. 01, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Company ") announces that, further to the merger agreement with Cann Pharmaceutical Ltd.